Nov 27, 2019 - The stock market closed at a record high today as the DJIA rose over 42 points and the S&P 500 gained 0.4%.
Nov 20, 2019 - Alkermes (ALKS) submits NDA to the FDA seeking approval of ALKS 3831 for the treatment of schizophrenia and bipolar I disorder.
Nov 19, 2019 - Aerie (AERI) will acquire Spanish ophthalmic pharmaceutical company, Avizorex Pharma, to add a mid-stage dry eye disease candidate to its pipeline.
Nov 12, 2019 - Top Stock Reports for Booking Holdings, Allergan & Honda Motor Co.
Nov 08, 2019 - Teva Pharmaceutical (TEVA) misses earnings estimate but beats the same for sales. The company increases the lower end of its 2019 sales and earnings guidance. Shares rise.
Nov 08, 2019 - Novo Nordisk (NVO) and Allergan (AGN) release Q3 results. FDA approves Sanofi's quadrivalent flu vaccine for older adults and Novartis' long-acting biosimilar version of Amgen's Neulasta.
Nov 05, 2019 - Allergan (AGN) delivered earnings and revenue surprises of 0.00% and 4.01%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?
Nov 05, 2019 - Botox, Juveederm fillers, Vraylar drive Allergan's (AGN) third-quarter sales, making up for loss of exclusivity on some brands and lower sales of eye drug, Restasis.
Nov 04, 2019 - Let us take a look at five drug/biotech companies, which are supposed to release their quarterly results on Nov 5.
Nov 04, 2019 - Allergan (AGN) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.